✦ LIBER ✦

Benefit of mycophenolate-mofetil (MMF) in patients with cyclosporine (CYA) induced nephropathy after cardiac transplantation

✍ Scribed by A. Zuckermann; M. Ploner; Ü. Keziban; M. Czerny; E. Wolner; G. Laufer; M. Grimm

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefits of mycophenolate mofetil in car

✍ V Sánchez; J.F Delgado; T Blasco; R Dalmau; J.M Morales; P Escribano; R Tello; J 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Benefit of mycophenolate mofetil in pati

✍ A Zuckermann; T Birsan; S Thaghavi; N Kupilik; E Deviatko; G Dekan; E Wolner; W 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Tacrolimus with Mycophenolate Mofetil (M

✍ J. A. Kobashigawa; L. W. Miller; S. D. Russell; G. A. Ewald; M. J. Zucker; L. R. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Conversion to mycophenolate mofetil (MMF

✍ J.I. Herrero; J. Quiroga; B. Sangro; M. Girala; N. Gómez; A. Beltrán; F. Pardo; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Chronic cyclosporine-induced nephrotoxic

✍ V. Sanchez; J.F. Delgado; J.M. Morales; R. Tello; M.A. Gómez; P. Escribano; A.G. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Withdrawal of Cyclosporine or Tacrolimus

✍ Barbara Suwelack; Ulf Gerhardt; Helge Hohage 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB